Your browser doesn't support javascript.
loading
Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma.
Georgiou, Marina; Ntavelou, Panagiota; Stokes, William; Roy, Rajat; Maher, Geoffrey J; Stoilova, Tsvetana; Choo, Josephine A M Y; Rakhit, Callum P; Martins, Miguel; Ajuh, Paul; Horowitz, Neil; Berkowitz, Ross S; Elias, Kevin; Seckl, Michael J; Pardo, Olivier E.
Afiliação
  • Georgiou M; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Ntavelou P; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Stokes W; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Roy R; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Maher GJ; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Stoilova T; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Choo JAMY; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Rakhit CP; MRC Toxicology Unit, University of Cambridge, Cambridge, UK.
  • Martins M; MRC Toxicology Unit, University of Cambridge, Cambridge, UK.
  • Ajuh P; Gemini Biosciences, Liverpool, UK.
  • Horowitz N; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Berkowitz RS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Elias K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Seckl MJ; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK. m.seckl@imperial.ac.uk.
  • Pardo OE; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK. o.pardo@imperial.ac.uk.
Oncogene ; 41(26): 3510, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35637251
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido